Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cholesterol Homeostasis Modulates Platinum Sensitivity in Human Ovarian Cancer
Daniela Criscuolo, Rosario Avolio, Giovanni Calice, et al.
Cells (2020) Vol. 9, Iss. 4, pp. 828-828
Open Access | Times Cited: 49

Showing 1-25 of 49 citing articles:

Influence of cholesterol on cancer progression and therapy
Shyamananda Singh Mayengbam, Abhijeet Singh, Ajay D. Pillai, et al.
Translational Oncology (2021) Vol. 14, Iss. 6, pp. 101043-101043
Open Access | Times Cited: 113
Fat and Furious: Lipid Metabolism in Antitumoral Therapy Response and Resistance
Marina Bacci, Nicla Lorito, Alfredo Smiriglia, et al.
Trends in cancer (2020) Vol. 7, Iss. 3, pp. 198-213
Closed Access | Times Cited: 121
Nanoparticle Targeting in Chemo‐Resistant Ovarian Cancer Reveals Dual Axis of Therapeutic Vulnerability Involving Cholesterol Uptake and Cell Redox Balance
Yinu Wang, Andrea E. Calvert, Horacio Cárdenas, et al.
Advanced Science (2024) Vol. 11, Iss. 13
Open Access | Times Cited: 9
LDL, HDL and endocrine-related cancer: From pathogenic mechanisms to therapies
Giovanna Revilla, Lídia Cedó, Mireia Tondo, et al.
Seminars in Cancer Biology (2020) Vol. 73, pp. 134-157
Open Access | Times Cited: 52
The Biphasic Effect of Flavonoids on Oxidative Stress and Cell Proliferation in Breast Cancer Cells
Xiaomin Xi, Jiting Wang, Yue Qin, et al.
Antioxidants (2022) Vol. 11, Iss. 4, pp. 622-622
Open Access | Times Cited: 29
The frontier of live tissue imaging across space and time
Qiang Huang, Aliesha Garrett, Shree Bose, et al.
Cell stem cell (2021) Vol. 28, Iss. 4, pp. 603-622
Open Access | Times Cited: 40
Inhibition of XPO1 Sensitizes Small Cell Lung Cancer to First- and Second-Line Chemotherapy
Álvaro Quintanal-Villalonga, Hirokazu Taniguchi, Hao Yuan, et al.
Cancer Research (2021) Vol. 82, Iss. 3, pp. 472-483
Open Access | Times Cited: 33
Cancer therapy's impact on lipid metabolism: Mechanisms and future avenues
Roshni Bhatnagar, Neal M. Dixit, Eric H. Yang, et al.
Frontiers in Cardiovascular Medicine (2022) Vol. 9
Open Access | Times Cited: 23
The Lipid Metabolism as Target and Modulator of BOLD‐100 Anticancer Activity: Crosstalk with Histone Acetylation
Dina Baier, Theresa Mendrina, Beatrix Schoenhacker‐Alte, et al.
Advanced Science (2023) Vol. 10, Iss. 32
Open Access | Times Cited: 13
When cancer drug resistance meets metabolomics (bulk, single-cell and/or spatial): Progress, potential, and perspective
Zhiqiang Zhang, Chaohui Bao, Jiang Lu, et al.
Frontiers in Oncology (2023) Vol. 12
Open Access | Times Cited: 13
B7H3 increases ferroptosis resistance by inhibiting cholesterol metabolism in colorectal cancer
Haiyan Jin, Mengxin Zhu, Dongze Zhang, et al.
Cancer Science (2023) Vol. 114, Iss. 11, pp. 4225-4236
Open Access | Times Cited: 10
IDH1 Targeting as a New Potential Option for Intrahepatic Cholangiocarcinoma Treatment—Current State and Future Perspectives
Fabiana Crispo, Michele Pietrafesa, Valentina Condelli, et al.
Molecules (2020) Vol. 25, Iss. 16, pp. 3754-3754
Open Access | Times Cited: 24
Statins: HMG-CoA Reductase Inhibitors as Potential Anticancer Agents against Malignant Neoplasms in Women
Anna Markowska, Michał Antoszczak, Janina Markowska, et al.
Pharmaceuticals (2020) Vol. 13, Iss. 12, pp. 422-422
Open Access | Times Cited: 24
Role of long noncoding RNA taurine‐upregulated gene 1 in cancers
Da Miao, Jing Zhuang, Zhou Yani, et al.
Molecular Medicine (2021) Vol. 27, Iss. 1
Open Access | Times Cited: 22
Mechanistic Insights Delineating the Role of Cholesterol in Epithelial Mesenchymal Transition and Drug Resistance in Cancer
Naaziyah Abdulla, C. Theresa Vincent, Mandeep Kaur
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 22
Targeting Mitochondrial Protein Expression as a Future Approach for Cancer Therapy
Daniela Criscuolo, Rosario Avolio, Danilo Swann Matassa, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 21
ABCA9, an ER cholesterol transporter, inhibits breast cancer cell proliferation via SREBP‐2 signaling
Hyeon‐Ji Hwang, Kang‐Hoon Lee, Je‐Yoel Cho
Cancer Science (2022) Vol. 114, Iss. 4, pp. 1451-1463
Open Access | Times Cited: 16
Enhancing Immunotherapy in Ovarian Cancer: The Emerging Role of Metformin and Statins
Diana Luísa Almeida-Nunes, Ricardo Silvestre, Ricardo Jorge Dinis‐Oliveira, et al.
International Journal of Molecular Sciences (2023) Vol. 25, Iss. 1, pp. 323-323
Open Access | Times Cited: 9
SIAH1 ubiquitination-modified HMGCR inhibits lung cancer progression and promotes drug sensitivity through cholesterol synthesis
Hongmei Yuan, Hongge Wu, Jing Cheng, et al.
Cancer Cell International (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 8
Cytosolic and mitochondrial translation elongation are coordinated through the molecular chaperone TRAP1 for the synthesis and import of mitochondrial proteins
Rosario Avolio, Ilenia Agliarulo, Daniela Criscuolo, et al.
Genome Research (2023) Vol. 33, Iss. 8, pp. 1242-1257
Open Access | Times Cited: 8
Aberrant Cholesterol Metabolism in Ovarian Cancer: Identification of Novel Therapeutic Targets
Jiangnan He, Michelle K.Y. Siu, Hys Ngan, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 20
Small Molecule Targeting of Oxysterol-Binding Protein (OSBP)-Related Protein 4 and OSBP Inhibits Ovarian Cancer Cell Proliferation in Monolayer and Spheroid Cell Models
Ryan C. Bensen, Gökhan Günay, Matthew C. Finneran, et al.
ACS Pharmacology & Translational Science (2021) Vol. 4, Iss. 2, pp. 744-756
Open Access | Times Cited: 18
Decreased Levels of GSH Are Associated with Platinum Resistance in High-Grade Serous Ovarian Cancer
Daniela Criscuolo, Rosario Avolio, Matteo Parri, et al.
Antioxidants (2022) Vol. 11, Iss. 8, pp. 1544-1544
Open Access | Times Cited: 14
Testis-expressed gene 11 inhibits cisplatin-induced DNA damage and contributes to chemoresistance in testicular germ cell tumor
Sachi Kitayama, Kazuhiro Ikeda, Wataru Sato, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 12
Regulation of mitochondrial complex III activity and assembly by TRAP1 in cancer cells
Danilo Swann Matassa, Daniela Criscuolo, Rosario Avolio, et al.
Cancer Cell International (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 12
Page 1 - Next Page

Scroll to top